The use of generic antiepileptic drugs (AEDs) in patients with epilepsy is controversial. The purpose of this study is to identify patient characteristics associated with increased odds of receiving a generic AED product. A large commercial database was used to identify patients with a primary diagnosis of epilepsy who were prescribed an AED during a three-month window. Data analysis found that those ≥ 65. years old had 15.7% greater odds of receiving a generic AED (OR = 1.157; 95% CI = 1.056-1.268). Patients with Medicaid were found to have 2.44 times the odds of having had a generic AED prescription (OR = 2.44; CI = 2.168-2.754). Patients residing in the Northeast had 12.6% decreased odds of receiving a generic AED (OR = 0.874; CI = 0.821-0.931). These patient characteristics could signify certain health care disparities and may represent potential confounders to future observational studies.
|Number of pages||6|
|Journal||Epilepsy and Behavior|
|State||Published - Jan 2013|
Bibliographical noteFunding Information:
The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health through Grant UL1RR033173 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
- Antiepileptic drugs
- Generic drugs
ASJC Scopus subject areas
- Clinical Neurology
- Behavioral Neuroscience